S-palmitoylation of PHGDH and FASN promotes chemoresistance in breast cancer, while palmitoylation of ACACA and GPX4 influences lipid metabolic reprogramming and ferroptosis resistance, respectively (35, 36). The gene discussed is FASN; the disease is breast carcinoma.